Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...

Debiopharm Research & Manufacturing S.A. (Debiopharm, a Swiss-based global biopharmaceutical company aiming to cure cancer and ...

Pleasanton, California - Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality ...

The US Food and Drug Administration (FDA) has approved an investigational new drug (IND) application from Aclaris ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special purpose acquisition company (SPAC) model to hop onto the Nasdaq. | Market ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...

Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more ...

FcRn blockade helps prevent fetal complications in HDFN by lowering harmful maternal antibodies and preventing severe ...

Additionally, in the framework of a licensing agreement and a collaborative endeavor to support innovative research, Debiopharm and Oncodesign Services will present promising new data illustrating how ...

Invenra Inc., a leader in multispecific antibody discovery and development, today announced the launch of its B-Body Expresstm Antibody Expression service. This new offering enables biotechnology and ...